Samsung Biologics

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Sustainability

Samsung Biologics earns EcoVadis Platinum Sustainability Rating

The CDMO has been ranked in the top one per cent of companies assessed by EcoVadis, reflecting strengthened sustainability management across environment, labour and human rights, ethics and sustainable procurement

Payload cleaning and analytics: overcoming the challenges of payload cleaning and analytics in ADC manufacturing

29 January 2026 | Virtual
Manufacturing

Developing strategies for robust chemistry, manufacturing and controls execution for advanced biologics

Chemistry, manufacturing and controls (CMC) is a fundamental discipline for complex drug development projects. It must be rigorously implemented to navigate stringent regulatory requirements before drug approval and commercialisation
Manufacturing

Accelerating technology transfer in biopharmaceutical manufacturing

This article explores how structured, digitally enabled and integrated technology transfer frameworks are accelerating the commercialisation of complex biopharmaceutical modalities by enhancing precision, speed and regulatory readiness
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Driving efficiency in biopharmaceutical manufacturing: the role of CDMOs and advanced technologies

CDMOs and advanced technologies enhance efficiency in biopharmaceutical manufacturing by integrating end-to-end services, leveraging automation and optimising processes and regulatory compliance
Manufacturing

Samsung Bioepis and Nipro sign biosimilar licensing and commercialisation deals

This partnership will expand Samsung Bioepis' Japanese footprint, while providing cost-effective and efficacious biosimilars to the Japanese healthcare landscape
Manufacturing

Samsung Biologics signs $514m manufacturing contract with US-based pharma company

The six year contract manufacturing deal will provide see Samsung Biologics produce pharmaceutical products for an undisclosed, US-based company
Subscribe now